nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—ADRA2C—attention deficit hyperactivity disorder	0.199	0.253	CbGaD
Risperidone—DRD4—attention deficit hyperactivity disorder	0.108	0.137	CbGaD
Risperidone—HTR1B—attention deficit hyperactivity disorder	0.096	0.122	CbGaD
Risperidone—DRD3—attention deficit hyperactivity disorder	0.0932	0.118	CbGaD
Risperidone—DRD1—attention deficit hyperactivity disorder	0.0915	0.116	CbGaD
Risperidone—ADRA2A—attention deficit hyperactivity disorder	0.085	0.108	CbGaD
Risperidone—DRD2—attention deficit hyperactivity disorder	0.0645	0.0819	CbGaD
Risperidone—HTR2A—attention deficit hyperactivity disorder	0.0499	0.0633	CbGaD
Risperidone—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.00474	0.0878	CbGeAlD
Risperidone—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00296	0.0547	CbGeAlD
Risperidone—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00252	0.0466	CbGeAlD
Risperidone—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00157	0.0291	CbGeAlD
Risperidone—Paliperidone—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.157	CrCbGaD
Risperidone—H1F0—forebrain—attention deficit hyperactivity disorder	0.000951	0.0176	CbGeAlD
Risperidone—DRD1—forebrain—attention deficit hyperactivity disorder	0.000939	0.0174	CbGeAlD
Risperidone—H1F0—cardiovascular system—attention deficit hyperactivity disorder	0.000804	0.0149	CbGeAlD
Risperidone—Iloperidone—ADRA2C—attention deficit hyperactivity disorder	0.000794	0.11	CrCbGaD
Risperidone—DRD4—brain—attention deficit hyperactivity disorder	0.000774	0.0143	CbGeAlD
Risperidone—HTR1B—forebrain—attention deficit hyperactivity disorder	0.000761	0.0141	CbGeAlD
Risperidone—HTR1D—forebrain—attention deficit hyperactivity disorder	0.000737	0.0136	CbGeAlD
Risperidone—HTR2C—forebrain—attention deficit hyperactivity disorder	0.00073	0.0135	CbGeAlD
Risperidone—DRD3—nervous system—attention deficit hyperactivity disorder	0.000712	0.0132	CbGeAlD
Risperidone—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000686	0.0127	CbGeAlD
Risperidone—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000685	0.0127	CbGeAlD
Risperidone—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000644	0.0119	CbGeAlD
Risperidone—H1F0—midbrain—attention deficit hyperactivity disorder	0.000628	0.0116	CbGeAlD
Risperidone—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000623	0.0115	CbGeAlD
Risperidone—DRD1—midbrain—attention deficit hyperactivity disorder	0.00062	0.0115	CbGeAlD
Risperidone—Paliperidone—DRD4—attention deficit hyperactivity disorder	0.000616	0.085	CrCbGaD
Risperidone—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000614	0.0114	CbGeAlD
Risperidone—HTR7—forebrain—attention deficit hyperactivity disorder	0.000587	0.0109	CbGeAlD
Risperidone—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.00058	0.0107	CbGeAlD
Risperidone—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000566	0.0105	CbGeAlD
Risperidone—DRD2—forebrain—attention deficit hyperactivity disorder	0.000555	0.0103	CbGeAlD
Risperidone—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000547	0.0101	CbGeAlD
Risperidone—Paliperidone—HTR1B—attention deficit hyperactivity disorder	0.000547	0.0755	CrCbGaD
Risperidone—KCNH2—forebrain—attention deficit hyperactivity disorder	0.000547	0.0101	CbGeAlD
Risperidone—DRD3—brain—attention deficit hyperactivity disorder	0.000544	0.0101	CbGeAlD
Risperidone—Paliperidone—DRD3—attention deficit hyperactivity disorder	0.000531	0.0733	CrCbGaD
Risperidone—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000527	0.00975	CbGeAlD
Risperidone—Paliperidone—DRD1—attention deficit hyperactivity disorder	0.000521	0.072	CrCbGaD
Risperidone—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000519	0.00962	CbGeAlD
Risperidone—H1F0—nervous system—attention deficit hyperactivity disorder	0.000516	0.00956	CbGeAlD
Risperidone—DRD1—nervous system—attention deficit hyperactivity disorder	0.00051	0.00944	CbGeAlD
Risperidone—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000503	0.00931	CbGeAlD
Risperidone—H1F0—central nervous system—attention deficit hyperactivity disorder	0.000497	0.00921	CbGeAlD
Risperidone—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.000496	0.00919	CbGeAlD
Risperidone—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000491	0.00909	CbGeAlD
Risperidone—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000487	0.00901	CbGeAlD
Risperidone—H1F0—cerebellum—attention deficit hyperactivity disorder	0.000486	0.009	CbGeAlD
Risperidone—Paliperidone—ADRA2A—attention deficit hyperactivity disorder	0.000484	0.0669	CrCbGaD
Risperidone—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000482	0.00892	CbGeAlD
Risperidone—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000479	0.00887	CbGeAlD
Risperidone—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000462	0.00856	CbGeAlD
Risperidone—HRH1—forebrain—attention deficit hyperactivity disorder	0.000438	0.00812	CbGeAlD
Risperidone—Iloperidone—DRD4—attention deficit hyperactivity disorder	0.000431	0.0595	CrCbGaD
Risperidone—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.00043	0.00797	CbGeAlD
Risperidone—ADRA1B—brain—attention deficit hyperactivity disorder	0.000418	0.00774	CbGeAlD
Risperidone—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000413	0.00765	CbGeAlD
Risperidone—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000406	0.00751	CbGeAlD
Risperidone—HTR1D—nervous system—attention deficit hyperactivity disorder	0.0004	0.00741	CbGeAlD
Risperidone—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000398	0.00737	CbGeAlD
Risperidone—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000396	0.00734	CbGeAlD
Risperidone—H1F0—brain—attention deficit hyperactivity disorder	0.000395	0.00731	CbGeAlD
Risperidone—DRD1—brain—attention deficit hyperactivity disorder	0.00039	0.00722	CbGeAlD
Risperidone—HTR7—midbrain—attention deficit hyperactivity disorder	0.000388	0.00718	CbGeAlD
Risperidone—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000385	0.00713	CbGeAlD
Risperidone—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000381	0.00706	CbGeAlD
Risperidone—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000372	0.00689	CbGeAlD
Risperidone—Iloperidone—DRD3—attention deficit hyperactivity disorder	0.000371	0.0513	CrCbGaD
Risperidone—Paliperidone—DRD2—attention deficit hyperactivity disorder	0.000367	0.0507	CrCbGaD
Risperidone—DRD2—midbrain—attention deficit hyperactivity disorder	0.000366	0.00679	CbGeAlD
Risperidone—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000366	0.00678	CbGeAlD
Risperidone—Iloperidone—DRD1—attention deficit hyperactivity disorder	0.000365	0.0503	CrCbGaD
Risperidone—KCNH2—midbrain—attention deficit hyperactivity disorder	0.000361	0.00669	CbGeAlD
Risperidone—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000358	0.00663	CbGeAlD
Risperidone—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000356	0.0066	CbGeAlD
Risperidone—Iloperidone—ADRA2A—attention deficit hyperactivity disorder	0.000339	0.0468	CrCbGaD
Risperidone—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000333	0.00618	CbGeAlD
Risperidone—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000333	0.00617	CbGeAlD
Risperidone—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000321	0.00594	CbGeAlD
Risperidone—HTR7—nervous system—attention deficit hyperactivity disorder	0.000319	0.0059	CbGeAlD
Risperidone—HTR1B—brain—attention deficit hyperactivity disorder	0.000316	0.00585	CbGeAlD
Risperidone—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000314	0.00581	CbGeAlD
Risperidone—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000309	0.00573	CbGeAlD
Risperidone—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000307	0.00569	CbGeAlD
Risperidone—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000307	0.00568	CbGeAlD
Risperidone—HTR1D—brain—attention deficit hyperactivity disorder	0.000306	0.00566	CbGeAlD
Risperidone—HTR2C—brain—attention deficit hyperactivity disorder	0.000303	0.00561	CbGeAlD
Risperidone—DRD2—nervous system—attention deficit hyperactivity disorder	0.000301	0.00558	CbGeAlD
Risperidone—HTR7—cerebellum—attention deficit hyperactivity disorder	0.0003	0.00555	CbGeAlD
Risperidone—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000297	0.0055	CbGeAlD
Risperidone—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000296	0.00548	CbGeAlD
Risperidone—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000293	0.00542	CbGeAlD
Risperidone—DRD2—central nervous system—attention deficit hyperactivity disorder	0.00029	0.00537	CbGeAlD
Risperidone—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000289	0.00536	CbGeAlD
Risperidone—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.000286	0.00529	CbGeAlD
Risperidone—HTR2B—brain—attention deficit hyperactivity disorder	0.000284	0.00527	CbGeAlD
Risperidone—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000284	0.00526	CbGeAlD
Risperidone—Paliperidone—HTR2A—attention deficit hyperactivity disorder	0.000284	0.0392	CrCbGaD
Risperidone—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000283	0.00525	CbGeAlD
Risperidone—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000282	0.00522	CbGeAlD
Risperidone—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.000279	0.00517	CbGeAlD
Risperidone—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000276	0.0051	CbGeAlD
Risperidone—Iloperidone—DRD2—attention deficit hyperactivity disorder	0.000257	0.0355	CrCbGaD
Risperidone—HTR1A—brain—attention deficit hyperactivity disorder	0.000255	0.00472	CbGeAlD
Risperidone—HTR7—brain—attention deficit hyperactivity disorder	0.000244	0.00451	CbGeAlD
Risperidone—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000242	0.00448	CbGeAlD
Risperidone—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00024	0.00444	CbGeAlD
Risperidone—HRH1—nervous system—attention deficit hyperactivity disorder	0.000238	0.00441	CbGeAlD
Risperidone—ADRA1A—brain—attention deficit hyperactivity disorder	0.000235	0.00435	CbGeAlD
Risperidone—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000234	0.00433	CbGeAlD
Risperidone—DRD2—brain—attention deficit hyperactivity disorder	0.00023	0.00426	CbGeAlD
Risperidone—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000229	0.00424	CbGeAlD
Risperidone—KCNH2—brain—attention deficit hyperactivity disorder	0.000227	0.0042	CbGeAlD
Risperidone—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000225	0.00417	CbGeAlD
Risperidone—ADRA2C—brain—attention deficit hyperactivity disorder	0.000224	0.00415	CbGeAlD
Risperidone—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.00022	0.00407	CbGeAlD
Risperidone—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000203	0.00376	CbGeAlD
Risperidone—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000199	0.00368	CbGeAlD
Risperidone—Iloperidone—HTR2A—attention deficit hyperactivity disorder	0.000199	0.0274	CrCbGaD
Risperidone—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000191	0.00354	CbGeAlD
Risperidone—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000187	0.00346	CbGeAlD
Risperidone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000184	0.00341	CbGeAlD
Risperidone—HRH1—brain—attention deficit hyperactivity disorder	0.000182	0.00337	CbGeAlD
Risperidone—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000181	0.00335	CbGeAlD
Risperidone—ADRA2A—brain—attention deficit hyperactivity disorder	0.000179	0.00331	CbGeAlD
Risperidone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000177	0.00328	CbGeAlD
Risperidone—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000174	0.00323	CbGeAlD
Risperidone—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00017	0.00315	CbGeAlD
Risperidone—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000158	0.00293	CbGeAlD
Risperidone—HTR2A—brain—attention deficit hyperactivity disorder	0.000152	0.00281	CbGeAlD
Risperidone—CYP2D6—brain—attention deficit hyperactivity disorder	0.000138	0.00256	CbGeAlD
Risperidone—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00013	0.00241	CbGeAlD
Risperidone—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000125	0.00232	CbGeAlD
Risperidone—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000123	0.00227	CbGeAlD
Risperidone—ABCB1—brain—attention deficit hyperactivity disorder	9.95e-05	0.00184	CbGeAlD
Risperidone—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.06e-05	7e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.06e-05	6.99e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.05e-05	6.96e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.05e-05	6.94e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.05e-05	6.93e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.91e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.04e-05	6.91e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.04e-05	6.9e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.9e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.04e-05	6.88e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.04e-05	6.86e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.03e-05	6.84e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.03e-05	6.83e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.03e-05	6.81e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.03e-05	6.79e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.02e-05	6.77e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.02e-05	6.77e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.02e-05	6.77e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.7e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.01e-05	6.68e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.01e-05	6.66e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.66e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	9.98e-06	6.6e-05	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.98e-06	6.6e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.95e-06	6.58e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.93e-06	6.57e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.85e-06	6.52e-05	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.84e-06	6.51e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.8e-06	6.49e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.74e-06	6.45e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.69e-06	6.41e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	9.67e-06	6.4e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.64e-06	6.38e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	9.63e-06	6.37e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.61e-06	6.36e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.61e-06	6.36e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.59e-06	6.34e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.57e-06	6.34e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.56e-06	6.33e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.54e-06	6.31e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.52e-06	6.3e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.46e-06	6.26e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	9.41e-06	6.23e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.39e-06	6.21e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	9.38e-06	6.21e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.38e-06	6.21e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.37e-06	6.2e-05	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	9.28e-06	6.14e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.26e-06	6.13e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.26e-06	6.13e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.25e-06	6.12e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.23e-06	6.11e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.23e-06	6.1e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.18e-06	6.08e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.06e-06	5.99e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.96e-06	5.93e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.94e-06	5.92e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.94e-06	5.92e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.93e-06	5.91e-05	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.89e-06	5.88e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.87e-06	5.87e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.84e-06	5.85e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.82e-06	5.84e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	8.82e-06	5.84e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.81e-06	5.83e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.81e-06	5.83e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.79e-06	5.82e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	8.74e-06	5.78e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.7e-06	5.76e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.68e-06	5.74e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	8.68e-06	5.74e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.63e-06	5.71e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.61e-06	5.7e-05	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.58e-06	5.68e-05	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.53e-06	5.65e-05	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	8.52e-06	5.64e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.51e-06	5.63e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.49e-06	5.62e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.45e-06	5.59e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.36e-06	5.53e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.33e-06	5.51e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.3e-06	5.5e-05	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.3e-06	5.49e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.26e-06	5.47e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.2e-06	5.43e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.19e-06	5.42e-05	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.17e-06	5.41e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.11e-06	5.36e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.1e-06	5.36e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.09e-06	5.36e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	8.08e-06	5.35e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.08e-06	5.35e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.07e-06	5.34e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.07e-06	5.34e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.07e-06	5.34e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.03e-06	5.31e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.98e-06	5.28e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.96e-06	5.27e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	7.95e-06	5.26e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.81e-06	5.17e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.81e-06	5.17e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.79e-06	5.16e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.77e-06	5.14e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.75e-06	5.13e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.68e-06	5.09e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.64e-06	5.06e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.54e-06	4.99e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.54e-06	4.99e-05	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.53e-06	4.98e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.53e-06	4.98e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.5e-06	4.96e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.46e-06	4.94e-05	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	7.45e-06	4.93e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.42e-06	4.91e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.4e-06	4.9e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.4e-06	4.89e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.39e-06	4.89e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.31e-06	4.84e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.27e-06	4.81e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.26e-06	4.8e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	7.26e-06	4.8e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	7.26e-06	4.8e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.23e-06	4.78e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.14e-06	4.73e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.14e-06	4.73e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.1e-06	4.7e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.08e-06	4.69e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.05e-06	4.67e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.05e-06	4.67e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.03e-06	4.65e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.02e-06	4.64e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.97e-06	4.61e-05	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	6.96e-06	4.6e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.96e-06	4.6e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.92e-06	4.58e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.91e-06	4.57e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.84e-06	4.53e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.83e-06	4.52e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.82e-06	4.52e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.81e-06	4.5e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.8e-06	4.5e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	6.77e-06	4.48e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	6.74e-06	4.46e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	6.73e-06	4.45e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.72e-06	4.44e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.72e-06	4.44e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.59e-06	4.36e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.59e-06	4.36e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	6.58e-06	4.35e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.57e-06	4.35e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.54e-06	4.33e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	6.53e-06	4.32e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.48e-06	4.29e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.47e-06	4.28e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.46e-06	4.28e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.38e-06	4.22e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.36e-06	4.21e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	6.35e-06	4.2e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	6.34e-06	4.2e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.28e-06	4.15e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.27e-06	4.15e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.26e-06	4.14e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.26e-06	4.14e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.21e-06	4.11e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.19e-06	4.1e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.17e-06	4.08e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.17e-06	4.08e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.16e-06	4.07e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.15e-06	4.07e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.15e-06	4.07e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	6.12e-06	4.05e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	6.1e-06	4.04e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.1e-06	4.04e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.09e-06	4.03e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.08e-06	4.02e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	6.04e-06	4e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.04e-06	4e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	6e-06	3.97e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.97e-06	3.95e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.94e-06	3.93e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	5.9e-06	3.9e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	5.75e-06	3.8e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.75e-06	3.8e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	5.71e-06	3.78e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.68e-06	3.76e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.67e-06	3.76e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.66e-06	3.75e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	5.65e-06	3.74e-05	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	5.65e-06	3.74e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.58e-06	3.69e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.56e-06	3.68e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	5.54e-06	3.67e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.44e-06	3.6e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.35e-06	3.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	5.34e-06	3.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	5.31e-06	3.51e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.28e-06	3.49e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.26e-06	3.48e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	5.16e-06	3.42e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	4.9e-06	3.24e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.88e-06	3.23e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	4.86e-06	3.22e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.77e-06	3.15e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.64e-06	3.07e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.6e-06	3.05e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.59e-06	3.04e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.58e-06	3.03e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.45e-06	2.95e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.38e-06	2.9e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.37e-06	2.89e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.04e-06	2.67e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.97e-06	2.63e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.89e-06	2.58e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.76e-06	2.49e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	3.76e-06	2.49e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	3.7e-06	2.45e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	3.7e-06	2.45e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	3.67e-06	2.43e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	3.62e-06	2.39e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	3.48e-06	2.3e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.46e-06	2.29e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.44e-06	2.27e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.29e-06	2.18e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.27e-06	2.16e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.2e-06	2.12e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.15e-06	2.08e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.01e-06	1.99e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3e-06	1.99e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	2.91e-06	1.92e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.86e-06	1.89e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.84e-06	1.88e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	2.82e-06	1.87e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.8e-06	1.85e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.53e-06	1.67e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.44e-06	1.61e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.43e-06	1.61e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.36e-06	1.56e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.32e-06	1.54e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2.29e-06	1.52e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.28e-06	1.51e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.26e-06	1.5e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.14e-06	1.42e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.11e-06	1.39e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.1e-06	1.39e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	2.1e-06	1.39e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.06e-06	1.36e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.92e-06	1.27e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	1.58e-06	1.05e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.49e-06	9.88e-06	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	9.76e-07	6.46e-06	CbGpPWpGaD
